Kalvista Pharmaceuticals Correlations

KALV Stock

USD 12.50 0.25 2.04%

The current 90-days correlation between Kalvista Pharmaceuticals and Kura Oncology is 0.35 (i.e., Weak diversification). The correlation of Kalvista Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Kalvista Pharmaceuticals Correlation With Market

Weak diversification

The correlation between Kalvista Pharmaceuticals and DJI is 0.34 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Kalvista Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kalvista Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Kalvista Stock please use our How to Invest in Kalvista Pharmaceuticals guide.

Moving together with Kalvista Stock

0.82	LUCD	Lucid Diagnostics	Pair Corr
0.76	WM	Waste Management	Pair Corr
0.64	PG	Procter Gamble	Pair Corr
0.92	JNJ	Johnson Johnson	Pair Corr
0.61	MMM	3M Company	Pair Corr
0.89	T	ATT Inc Aggressive Push	Pair Corr
0.63	XOM	Exxon Mobil Corp Earnings Call This Week	Pair Corr
0.67	IBM	International Business	Pair Corr

Moving against Kalvista Stock

0.86	ASMB	Assembly Biosciences Earnings Call Today	Pair Corr
0.85	SCLX	Scilex Holding	Pair Corr
0.8	CDIOW	Cardio Diagnostics	Pair Corr
0.8	CMND	Clearmind Medicine Common	Pair Corr
0.6	CDIO	Cardio Diagnostics	Pair Corr
0.59	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.57	ELVN	Enliven Therapeutics Downward Rally	Pair Corr
0.57	OCEAW	Ocean Biomedical	Pair Corr
0.32	WMT	Walmart	Pair Corr
0.84	MSFT	Microsoft Aggressive Push	Pair Corr
0.73	CAT	Caterpillar	Pair Corr
0.71	HD	Home Depot	Pair Corr
0.7	DIS	Walt Disney	Pair Corr
0.42	BA	Boeing	Pair Corr
0.42	MRK	Merck Company	Pair Corr

Related Correlations Analysis

	CRNX	THRX	KURA	VRDN	REPL	NVCT	LYRA	KRON	GOSS	SNDX
CRNX		0.0	0.71	0.79	-0.05	-0.66	0.09	0.02	-0.68	-0.35	CRNX
THRX	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	THRX
KURA	0.71	0.0		0.66	0.45	-0.44	0.16	0.17	-0.42	0.18	KURA
VRDN	0.79	0.0	0.66		0.22	-0.63	0.18	0.41	-0.79	-0.18	VRDN
REPL	-0.05	0.0	0.45	0.22		0.01	0.28	0.59	0.05	0.71	REPL
NVCT	-0.66	0.0	-0.44	-0.63	0.01		-0.28	-0.33	0.83	0.16	NVCT
LYRA	0.09	0.0	0.16	0.18	0.28	-0.28		0.51	-0.01	0.43	LYRA
KRON	0.02	0.0	0.17	0.41	0.59	-0.33	0.51		-0.27	0.4	KRON
GOSS	-0.68	0.0	-0.42	-0.79	0.05	0.83	-0.01	-0.27		0.4	GOSS
SNDX	-0.35	0.0	0.18	-0.18	0.71	0.16	0.43	0.4	0.4		SNDX
	CRNX	THRX	KURA	VRDN	REPL	NVCT	LYRA	KRON	GOSS	SNDX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

GOSS	+ 0.83	NVCT
VRDN	+ 0.79	CRNX
KURA	+ 0.71	CRNX
SNDX	+ 0.71	REPL
VRDN	+ 0.66	KURA
KRON	+ 0.59	REPL

High negative correlations

GOSS	- 0.79	VRDN
GOSS	- 0.68	CRNX
NVCT	- 0.66	CRNX
NVCT	- 0.63	VRDN
NVCT	- 0.44	KURA
GOSS	- 0.42	KURA

Risk-Adjusted Indicators

There is a big difference between Kalvista Stock performing well and Kalvista Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Kalvista Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CRNX	2.56	(0.64)	0.00	(0.51)	0.00	0.00	3.78	(6.70)	19.41
THRX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
KURA	2.44	(0.43)	0.00	(0.53)	0.00	0.00	5.18	(5.91)	13.72
VRDN	2.62	(0.48)	0.00	(0.45)	0.00	0.00	4.19	(5.61)	13.48
REPL	2.82	(0.08)	0.00	(0.06)	0.00	0.00	5.86	(4.75)	23.59
NVCT	4.19	0.94	0.20	3.67	4.12	(4.84)	9.96	(7.32)	26.68
LYRA	2.88	(0.09)	0.00	0.36	0.00	0.00	5.88	(5.88)	26.90
KRON	1.70	(0.17)	0.00	(0.25)	0.00	0.00	3.19	(3.16)	12.10
GOSS	4.35	0.73	0.14	(0.61)	4.64	(4.96)	9.84	(7.91)	21.24
SNDX	2.39	0.02	0.01	0.02	2.96	(2.49)	6.51	(5.07)	15.51

Kalvista Pharmaceuticals Corporate Management

Jarrod Aldom	Vice Communications	Profile
Nicole Sweeny	Chief Officer	Profile
Ryan Baker	Head Relations	Profile
Brian Piekos	Chief Officer	Profile
John McKune	VP Fin	Profile
Thomas MBA	CEO Director	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC